Correlation Between Mineralys Therapeutics, and Ideaya Biosciences
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Ideaya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Ideaya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Ideaya Biosciences, you can compare the effects of market volatilities on Mineralys Therapeutics, and Ideaya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Ideaya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Ideaya Biosciences.
Diversification Opportunities for Mineralys Therapeutics, and Ideaya Biosciences
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Ideaya is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Ideaya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ideaya Biosciences and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Ideaya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ideaya Biosciences has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Ideaya Biosciences go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Ideaya Biosciences
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.7 times more return on investment than Ideaya Biosciences. However, Mineralys Therapeutics, is 1.7 times more volatile than Ideaya Biosciences. It trades about -0.03 of its potential returns per unit of risk. Ideaya Biosciences is currently generating about -0.12 per unit of risk. If you would invest 1,396 in Mineralys Therapeutics, Common on August 30, 2024 and sell it today you would lose (85.00) from holding Mineralys Therapeutics, Common or give up 6.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Ideaya Biosciences
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Ideaya Biosciences |
Mineralys Therapeutics, and Ideaya Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Ideaya Biosciences
The main advantage of trading using opposite Mineralys Therapeutics, and Ideaya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Ideaya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ideaya Biosciences will offset losses from the drop in Ideaya Biosciences' long position.| Mineralys Therapeutics, vs. Evolution Gaming Group | Mineralys Therapeutics, vs. Mativ Holdings | Mineralys Therapeutics, vs. CF Industries Holdings | Mineralys Therapeutics, vs. The Mosaic |
| Ideaya Biosciences vs. Ikena Oncology | Ideaya Biosciences vs. Eliem Therapeutics | Ideaya Biosciences vs. HCW Biologics | Ideaya Biosciences vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |